Abstract
Alzheimer’s disease is characterised by regional neuronal degeneration, synaptic loss, and the progressive deposition of the 4 kDa β-amyloid peptide (Aβ) in senile plaques and accumulation of tau protein as neurofibrillary tangles. Aβ derives from the larger precursor molecule, amyloid precursor protein (APP) by proteolytic processing via β- and γ-secretases. While APP expression is well documented in neurons and astrocytes, the case for oligodendrocytes is less clear. The latter cell type is reported to express different isoforms of APP, and we have confirmed this observation by immunocytochemistry in cultures of differentiated rat cortical oligodendrocytes. Moreover, by means of a sensitive electrochemiluminescent immunoassay employing Aβ C-terminal specific antibodies, mature oligodendrocytes are shown to secrete the 40 and 42 amino acid Aβ species (Aβ40 and Aβ42). Secretion of Aβ peptides was reduced by incubating oligodendrocytes with α- and β-secretase inhibitors, or a γ-secretase inhibitor. Disturbances of APP processing and/or synthesis in oligodendrocytes may account for some myelin disorders observed in Alzheimer’s disease and other senile dementias.
This is a preview of subscription content, log in to check access.
References
-
1.
Glenner GG, Wong CW (1984) Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885–890
-
2.
Goedert M, Wischik CM, Crowther RA et al (1988) Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci USA 85:4051–4055
-
3.
Selkoe DJ (1994) Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer’s disease. Annu Rev Cell Biol 10:373–403
-
4.
Selkoe DJ (2002) Alzheimer’s disease is a synaptic failure. Science 298:789–791
-
5.
Selkoe DJ (2003) Folding proteins in fatal ways. Nature 42:900–904
-
6.
Walsh DM, Selkoe DJ (2004) Deciphering the molecular basis of memory failure in Alzheimer’s disease. Neuron 44:181–193
-
7.
Walsh DM, Klyubin I, Fadeeva JV et al (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535–539
-
8.
Meyer-Luehmann M, Spires-Jones TL, Prada C et al (2008) Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease. Nature 451:720–724
-
9.
Billings LM, Oddo S, Green KN et al (2005) Intraneuronal Aβ causes the onset of early Alzheimer’s disease-related cognitive deficits in transgenic mice. Neuron 45:675–688
-
10.
Goedert M (1987) Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer’s disease. EMBO J 6:3627–3632
-
11.
Mita S, Schon EA, Herbert J (1989) Widespread expression of amyloid beta-protein precursor gene in rat brain. Am J Pathol 134:1253–1261
-
12.
Selkoe DJ, Podlisny MB, Joachim CL et al (1988) β-Amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci USA 85:7341–7345
-
13.
Card JP, Meade RP, Davis LG (1988) Immunocytochemical localization of the precursor protein for β-amyloid in the rat central nervous system. Neuron 1:835–846
-
14.
Kawarabayashi T, Shoji M, Harigaya Y et al (1991) Amyloid β/A4 protein precursor is widely distributed in both the central and peripheral nervous systems of the mouse. Brain Res 552:1–7
-
15.
Beach TG, Walker R, McGeer EG (1989) Patterns of gliosis in Alzheimer’s disease and aging cerebrum. Glia 2:420–436
-
16.
Perlmutter LS, Barron E, Chui HC (1990) Morphologic association between microglia and senile plaque amyloid in Alzheimer’s disease. Neurosci Lett 119:32–36
-
17.
Yamaguchi H, Nakazato Y, Yamazaki T et al (1991) Subpial β/A4 amyloid deposition occurs between astroglial processes in Alzheimer-type dementia. Neurosci Lett 223:217–220
-
18.
Berkenbosch F, Refolo LM, Fiedrich VL Jr et al (1990) The Alzheimer’s amyloid precursor protein is produced by Type I astrocytes in primary cultures of rat neuroglia. J Neurosci Res 25:431–440
-
19.
Haass C, Hung AY, Selkoe DJ (1991) Processing of β-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion. J Neurosci 11:3783–3793
-
20.
Ohyagi Y, Tabira T (1993) Effect of growth factors and cytokines on expression of amyloid beta protein precursor mRNAs in cultured neural cells. Mol Brain Res 18:127–132
-
21.
Garcia-Ladona FJ, Huss Y, Frey P et al (1997) Oligodendrocytes express different isoforms of β-amyloid precursor protein in chemically defined cell culture conditions: in situ hybridization and immunocytochemical detection. J Neurosci Res 50:50–61
-
22.
Mizuguchi M, Ikeda K, Kim SU (1992) Beta-amyloid precursor protein of Alzheimer’s disease in cultured bovine oligodendrocytes. J Neurosci Res 32:34–42
-
23.
Mizuguchi M, Ikeda K, Kim SU (1992) Differential distribution of cellular forms of β-amyloid precursor protein in murine glial cell cultures. Brain Res 584:219–225
-
24.
Palacios G, Palacios JM, Mengod G et al (1992) β-Amyloid precursor protein localization in the Golgi apparatus in neurons and oligodendrocytes. An immunocytochemical structural and ultrastructural study in normal and axotomized neurons. Mol Brain Res 15:195–206
-
25.
Solà C, García-Ladona FJ, Mengod G et al (1993) Increased levels of the Kunitz protease inhibitor-containing βAPP mRNAs in rat brain following neurotoxic damage. Mol Brain Res 17:41–52
-
26.
Solà C, García-Ladona FJ, Sarasa M et al (1993) βAPP gene expression is increased in the rat brain after motor neuron axotomy. Eur J Neurosci 5:795–808
-
27.
Guiroy DC, Bogucki A, Papierz W et al (1991) Amyloid β-protein in cerebral amyloid angiopathy, senile plaques, and preamyloidotic lesions in subcortical arteriosclerotic encephalopathy (Binswanger disease). Neurosci Lett 124:31–34
-
28.
Brun A, Englund E (1986) A white matter disorder in dementia of the Alzheimer Type: a pathoanatomical study. Ann Neurol 19:253–262
-
29.
Chia LS, Thompson JE, Moscarello MA (1984) X-ray diffraction evidence for myelin disorder in brain from humans with Alzheimer’s disease. Biochim Biophys Acta 775:308–312
-
30.
London E, de Leon MJ, George AE et al (1986) Periventricular lucencies in the CT scans of aged and demented patients. Biol Psychiatry 21:960–962
-
31.
Hussain I, Hawkins J, Harrison D et al (2007) Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases β-cleavage of amyloid precursor protein and amyloid-β production in vivo. J Neurochem 100:802–809
-
32.
Barten DM, Guss VL, Corsa JA et al (2005) Dynamics of β-amyloid reductions in brain, cerebrospinal fluid, and plasma of β-amyloid precursor protein transgenic mice treated with a γ-secretase inhibitor. J Pharmacol Exp Ther 312:635–643
-
33.
Rosin C, Bates TE, Skaper SD (2004) Excitatory amino acid induced oligodendrocyte cell death in vitro: receptor-dependent and -independent mechanisms. J Neurochem 90:1173–1185
-
34.
Skaper SD, Facci L, Milani D (1990) Culture and use of primary and clonal neural cells. In: Conn PM et al (eds) Methods in neurosciences, vol 2. Academic Press, San Diego, pp 17–33
-
35.
Prinjha R, Moore SE, Vinson M et al (2000) Inhibitor of neurite outgrowth in humans. Nature 403:383–384
-
36.
Back SA, Gan X, Li Y et al (1998) Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 18:6241–6253
-
37.
Huber AB, Weinmann O, Brösamle C et al (2002) Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci 22:3553–3567
-
38.
Taketomi M, Kinoshita N, Kimura K et al (2002) Nogo-A expression in mature oligodendrocytes of rat spinal cord in association with specific molecules. Neurosci Lett 332:37–40
-
39.
Hussain I, Powell D, Howlett DR et al (1999) Identification of a novel aspartic protease (Asp2) as β-secretase. Mol Cell Neurosci 14:419–427
-
40.
Vassar R, Bennett BD, Babu-Khan S et al (1999) β-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735–741
-
41.
Gegelashvili G, Schousboe A, Linnemann D (1994) Expression of amyloid precursor protein (APP) in rat brain and cultured neural cells. Int J Dev Neurosci 12:703–708
-
42.
Golde TE, Estus S, Usiak M et al (1990) Expression of β amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer’s disease using PCR. Neuron 4:253–267
-
43.
Oltersdorf T, Fritz LC, Schenk DB et al (1989) The secreted form of Alzheimer’s amyloid precursor protein with the Kunitz domain is protease nexin-II. Nature 341:144–147
-
44.
Weidemann A, König G, Bunke D et al (1989) Identification, biogenesis, and localization of precursors of Alzheimer’s disease A4 amyloid protein. Cell 57:115–126
-
45.
Kitaguchi N, Takahashi Y, Tokushima Y et al (1988) Novel precursor of Alzheimer’s disease amyloid protein shows protease inhibitory activity. Nature 331:530–532
-
46.
Ponte P, Gonzalez-DeWhitt P, Schilling J et al (1988) A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 331:525–527
-
47.
Lacor PN, Buniel MC, Furlow PW et al (2007) Aβ oligomer-induced aberrations in synapse composition, shape and density provide a molecular basis for loss of connectivity in Alzheimer’s disease. J Neurosci 27:796–807
-
48.
Tanzi RE, Bertram L (2005) Twenty years of Alzheimer’s disease amyloid hypothesis: a genetic perspective. Cell 120:545–555
-
49.
Lefranc-Jullien S, Lisowski V, Hernandez JF et al (2005) Design and characterization of a new cell-permeant inhibitor of the β-secretase BACE1. Br J Pharmacol 145:228–235
-
50.
Asai M, Hattori C, Iwata N et al (2006) The novel β-secretase inhibitor KMI-429 reduces amyloid β peptide production in amyloid precursor protein transgenic and wild-type mice. J Neurochem 96:533–540
-
51.
Ghosh AK, Kumaragurubaran N, Hong L et al (2007) Design, synthesis, and X-ray structure of potent memapsin 2 (β-secretase) inhibitors with isophthalamide derivatives as the P2–P3-ligands. J Med Chem 50:2399–2407
-
52.
Nishitomi K, Sakaguchi G, Horikoshi Y et al (2006) BACE1 inhibition reduces endogenous A beta and alters APP processing in wild-type mice. J Neurochem 99:1555–1563
-
53.
Waxman SG (1977) Conduction in myelinated, unmyelinated, and demyelinated fibers. Arch Neurol 34:585–589
-
54.
Bartzokis G, Beckson M, Lu PH et al (2001) Age-related changes in frontal and temporal lobe volumes in men. Arch Gen Psychiatry 58:461–465
-
55.
Fuster JM (1997) Network memory. Trends Neurosci 20:451–459
-
56.
Mesulam MM (1999) Neuroplasticity failure in Alzheimer’s disease: bridging the gap between plaques and tangles. Neuron 24:521–529
-
57.
Felts PA, Baker TA, Smith KJ (1997) Conduction in segmentally demyelinated mammalian central axons. J Neurosci 17:7267–7277
-
58.
O’Sullivan M, Jones DK, Summers PE et al (2001) Evidence for cortical “disconnection” as a mechanism of age-related cognitive decline. Neurology 57:632–638
-
59.
Braak H, Del Tredici K, Schultz C et al (2000) Vulnerability of select neuronal types to Alzheimer’s disease. Ann NY Acad Sci 924:53–61
-
60.
Pakkenberg B, Pelvig D, Marner L et al (2003) Aging and the human neocortex. Exp Gerontol 38:95–99
-
61.
Hu X, Hicks CW, He W et al (2006) Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci 9:1520–1525
-
62.
Hu X, He W, Diaconu C et al (2008) Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves. FASEB J 22:2970–2980
-
63.
Bresnahan JC (1978) An electron-microscopic analysis of axonal alterations following blunt contusion of the spinal cord of the rhesus monkey (Macaca mulatta). J Neurol Sci 37:59–82
-
64.
Miller AK, Alston RL, Corsellis JA (1980) Variation with age in the volumes of grey and white matter in the cerebral hemispheres of man: measurements with an image analyzer. Neuropathol Appl Neurobiol 6:119–132
-
65.
Hinman JD, Abraham CR (2007) What’s behind the decline? The role of white matter in brain aging. Neurochem Res 32:2023–2031
-
66.
Bartzokis G (2004) Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease. Neurobiol Aging 25:5–18
-
67.
Bartzokis G, Beckson M, Lu PH et al (2000) Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research. Psychiatry Res 98:93–102
-
68.
Roth AD, Ramírez G, Alarcón R et al (2005) Oligodendrocytes damage in Alzheimer’s disease: beta amyloid toxicity and inflammation. Biol Res 38:381–387
-
69.
Xu J, Chen S, Ahmed SH et al (2001) Amyloid-β peptides are cytotoxic to oligodendrocytes. J Neurosci 21:RC118
-
70.
Lee JT, Xu J, Lee JM et al (2004) Amyloid-β peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol 164:123–131
-
71.
Chen S, Lee JM, Zeng C et al (2006) Amyloid beta peptide increases DP5 expression via activation of neutral sphingomyelinase and JNK in oligodendrocytes. J Neurochem 97:631–640
Acknowledgments
We wish to thank Dr. Martyn Evans for help with the confocal microscopy. Claudia Rosin was supported by Biotechnology and Biological Sciences Research Council Industrial Partnership CASE studentship 01/A4/C/07710.
Author information
Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Skaper, S.D., Evans, N.A., Soden, P.E. et al. Oligodendrocytes are a Novel Source of Amyloid Peptide Generation. Neurochem Res 34, 2243–2250 (2009). https://doi.org/10.1007/s11064-009-0022-9
Received:
Accepted:
Published:
Issue Date:
Keywords
- Oligodendrocytes
- Amyloid peptides
- Secretases
- Cortex
- Alzheimer’s disease
- Neurodegeneration